Apathy is a common phenomenon in late-life depression and is associated with poor outcomes. Apathy is often unrecognized in older depressed adults, and efficacious treatment options are lacking. This review provides a systematic review of the neuroanatomical abnormalities associated with apathy in late-life depression. In addition, the review summarizes the neuroimaging findings from studies of neurodegenerative and focal brain injury conditions that frequently present with apathy. The goal is to elucidate cerebral network abnormalities that give rise to apathy in older adults with mood disturbances and to inform future treatment targets.
Method:
Systematic literature review.
Results:
The few studies that have directly examined the neuroanatomical abnormalities of apathy in late-life depression suggest disturbances in the anterior cingulate cortex, insula, orbital and dorsal prefrontal cortex, striatum, and limbic structures (ie, amygdala, thalamus, and hippocampus). Studies examining the neuroanatomical correlates of apathy in other aging populations are consistent with the pattern observed in late-life depression.
Conclusions:
Apathy in late-life depression appears to be accompanied by neuroanatomical abnormalities in the salience and reward networks. These network findings are consistent with that observed in individuals presenting with apathy in other aging-related conditions. These findings may inform future treatments that target apathy.
LampeIKHeerenTJ. Is apathy in late-life depressive illness related to age-at-onset, cognitive function or vascular risk?Int Psychogeriatr. 2004;16(4):481–486.
2.
OnyikeCUSheppardJMTschanzJT, et al.Epidemiology of apathy in older adults: The Cache County Study. Am J Geriatr Psychiatry. 2007;15(5):365–375.
3.
MehtaMWhyteELenzeE, et al.Depressive symptoms in late life: associations with apathy, resilience and disability vary between young-old and old-old. Int J Geriatr Psychiatry. 2008;23(3):238–243.
4.
Groeneweg-KoolhovenIComijsHCNaardingP, et al.Presence and correlates of apathy in non-demented depressed and non-depressed older persons. Eur J Psychiat. 2015;29(2):119–130.
5.
WongpakaranNvan ReekumRWongpakaranTClarkeD. Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study. Ann Gen Psychiatry. 2007;6:7.
6.
StarksteinSEFedoroffJPPriceTRLeiguardaRRobinsonRG. Apathy following cerebrovascular lesions. Stroke. 1993;24(11):1625–1630.
7.
Groeneweg-KoolhovenIPloegMComijsHC, et al.Apathy in early and late-life depression. J Affect Disord. 2017;223:76–81.
8.
YuenGSGunningFMWoodsEKlimstraSAHoptmanMJAlexopoulosGS. Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response. J Affect Disord. 2014;166:179–186.
9.
FunesCMLavretskyHErcoliLSt CyrNSiddarthP. Apathy mediates cognitive difficulties in geriatric depression. Am J Geriatr Psychiatry. 2018;26(1):100–106.
10.
ReyesSViswanathanAGodinO, et al.Apathy: a major symptom in CADASIL. Neurology. 2009;72(10):905–910.
11.
HölttäEHLaakkonenMLLaurilaJVStrandbergTETilvisRSPitkäläKH. Apathy: prevalence, associated factors, and prognostic value among frail, older inpatients. J Am Med Dir Assoc. 2012;13(6):541–545.
12.
Groeneweg-KoolhovenIde WaalMWvan der WeeleGMGusseklooJvan der MastRC. Quality of life in community-dwelling older persons with apathy. Am J Geriatr Psychiatry. 2014;22(2):186–194.
13.
LevyMLCummingsJLFairbanksLA, et al.Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998;10(3):314–319.
14.
DoodyRSMassmanPMahurinRLawS. Positive and negative neuropsychiatric features in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci. 1995;7(1):54–60.
15.
ClarkeDEKoJYLyketsosCRebokGWEatonWW. Apathy and cognitive and functional decline in community-dwelling older adults: results from the Baltimore ECA longitudinal study. Int Psychogeriatr. 2010;22(05):819–829.
16.
MegaMSMastermanDMO’connorSMBarclayTRCummingsJL. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Arch Neurol. 1999;56(11):1388–1393.
17.
TattanTMCreedFH. Negative symptoms of schizophrenia and compliance with medication. Schizophr Bull. 2001;27(1):149–155.
18.
KopelowiczALibermanRPMintzJZarateR. Comparison of efficacy of social skills training for deficit and nondeficit negative symptoms in schizophrenia. Am J Psychiatry. 1997;154(3):424–425.
19.
LavretskyHLesserIMWohlMMillerBLMehringerCM. Clinical and neuroradiologic features associated with chronicity in late-life depression. Am J Geriatr Psychiatry. 1999;7(4):309–316.
20.
LevkovitzYSheerAHarelEV, et al.Differential effects of deep TMS of the prefrontal cortex on apathy and depression. Brain Stimul. 2011;4(4):266–274.
van ReekumRStussDTOstranderL. Apathy: why care?J Neuropsychiatry Clin Neurosci. 2005;17(1):7–19.
23.
LeontjevasRTeerenstraSSmalbruggeM, et al.More insight into the concept of apathy: a multidisciplinary depression management program has different effects on depressive symptoms and apathy in nursing homes. Int Psychogeriatr. 2013;25(12):1941–1952.
24.
LanctôtKLAgüera-OrtizLBrodatyH, et al.Apathy associated with neurocognitive disorders: recent progress and future directions. Alzheimers Dement. 2017;13(1):84–100.
25.
ChaseTN. Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment. Neurotox Res. 2011;19(2):266–278.
26.
StussDTVan ReekumRMurphyKJ. Differentiation of states and causes of apathy. In BorodJC, ed., Series in Affective Science: The Neuropsychology of Emotion. New York, NY: Oxford University Press; 2000:340–363.
27.
LevyRDuboisB. Apathy and the functional anatomy of the prefrontal cortex–basal ganglia circuits. Cereb Cortex. 2006;16(7):916–928.
28.
BerridgeKCRobinsonTEAldridgeJW. Dissecting components of reward: ‘liking,’ ‘wanting,’ and learning. Curr Opin in Pharmacol. 2009;9(1):65–73.
29.
BerridgeKCKringelbachML. Pleasure systems in the brain. Neuron. 2015;86(3):646–664.
30.
ZhangJBerridgeKCTindellAJSmithKSAldridgeJW. A neural computational model of incentive salience. PLoS Comput Biol. 2009;5(7):e1000437.
31.
PoolEBroschTDelplanqueSSanderD.Attentional bias for positive emotional stimuli: a meta-analytic investigation. Psychol Bull. 2016;142(1):79–106.
32.
HildebrandCTaylorMBradwayC. Elder self-neglect: the failure of coping because of cognitive and functional impairments. J Am Assoc Nurse Pract. 2014;26(8):452–462.
33.
HaberSN. Neuroanatomy of reward: a view from the ventral striatum. In GottfriedJA, ed. Neurobiology of Sensation and Reward. Boca Raton, FL: CRC Press; 2011:235.
MarinRS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991;3(3):243–254.
36.
RobertPOnyikeCULeentjensAF, et al.Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders. Eur Psychiatry. 2009;24(2):98–104.
37.
LevyRCzerneckiV.Apathy and the basal ganglia. J Neurol. 2006;253:VII54–VII61.
38.
LevyR. Apathy: a pathology of goal-directed behaviour. A new concept of the clinic and pathophysiology of apathy. Rev Neurol (Paris). 2012;168(8-9):585–597.
39.
AlexopoulosGSHoptmanMJYuenG, et al.Functional connectivity in apathy of late-life depression: a preliminary study. J Affect Disord. 2013;149(1):398–405.
40.
YuenGSGunning-DixonFMHoptmanMJ, et al.The salience network in the apathy of late-life depression. Int J Geriatr Psychiatry. 2014;29(11):1116–1124.
41.
LavretskyHZhengLWeinerMW, et al.The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. Int J Geriatr Psychiatry. 2008;23(10):1040–1050.
42.
LavretskyHBallmaierMPhamDTogaAKumarA. Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study. Am J Geriatr Psychiatry. 2007;15(5):386–394.
43.
EyreHASiddarthPvan DykK, et al.Neural correlates of apathy in late-life depression: a pilot [18F] FDDNP positron emission tomography study. Psychogeriatrics. 2017;17(3):186–193.
44.
CraigAHCummingsJLFairbanksL, et al.Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neurol. 1996;53(11):1116–1120.
45.
OtaMSatoNNakataYArimaKUnoM. Relationship between apathy and diffusion tensor imaging metrics of the brain in Alzheimer’s disease. Int J Geriatr Psychiatry. 2012;27(7):722–726.
46.
MarshallGAMonserrattLHarwoodDMandelkernMCummingsJLSultzerDL. Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol. 2007;64(7):1015–1020.
47.
KimJWLeeDYChooIH, et al.Microstructural alteration of the anterior cingulum is associated with apathy in Alzheimer disease. Am J Geriatr Psychiatry. 2011;19(7):644–653.
48.
ParadisoSChemerinskiEYaziciKMTartaroARobinsonRG. Frontal lobe syndrome reassessed: comparison of patients with lateral or medial frontal brain damage. J Neurol Neurosurg Psychiatry. 1999;67(5):664–667.
49.
BarrashJTranelDAndersonSW. Acquired personality disturbances associated with bilateral damage to the ventromedial prefrontal region. Dev Neuropsychol. 2000;18(3):355–381.
50.
KnutsonKMMonteODRaymontVWassermannEMKruegerFGrafmanJ. Neural correlates of apathy revealed by lesion mapping in participants with traumatic brain injuries. Hum Brain Mapp. 2014;35(3):943–953.
51.
AnderssonSKrogstadJFinsetA. Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity. Psychol Med. 1999;29(2):447–456.
52.
OkadaKKobayashiSYamagataSTakahashiKYamaguchiS. Poststroke apathy and regional cerebral blood flow. Stroke. 1997;28(12):2437–2441.
53.
YangSRShangXYTaoJLiuJYHuaP. Voxel-based analysis of fractional anisotropy in post-stroke apathy. PLoS One. 2015;10(1):e116168.
54.
TayJTuladharAMHollocksMJ, et al.Apathy is associated with large-scale white matter network disruption in small vessel disease. Neurology. 2019;92(11):e1157–e1167. doi:10.1212/WNL. 0000000000007095.
55.
Lisiecka-FordDMTozerDJMorrisRGLawrenceAJBarrickTRMarkusHS. Involvement of the reward network is associated with apathy in cerebral small vessel disease. J Affect Disord. 2018;232:116–121.
56.
Le HeronCManoharSPlantO, et al.Dysfunctional effort-based decision-making underlies apathy in genetic cerebral small vessel disease. Brain. 2018;141(11):3193–3210.
57.
HamaSYamashitaHShigenobuM, et al.Depression or apathy and functional recovery after stroke. Int J Geriatr Psychiatry. 2007;22(10):1046–1051.
58.
OnodaKKurodaYYamamotoY, et al.Post-stroke apathy and hypoperfusion in basal ganglia: SPECT study. Cerebrovasc Dis. 2011;31(1):6–11.
59.
LanctôtKLMoosaSHerrmannN, et al.A SPECT study of apathy in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2007;24(1):65–72.
60.
SultzerDLMelroseRJNarvaezTA, et al.Apathy and regional cholinergic receptor binding in Alzheimer’s disease: 2-FA PET imaging. Am J Geriatr Psychiatry. 2016;24(3):S135–S36.
61.
StantonBRLeighPNHowardRJBarkerGJBrownRG. Behavioural and emotional symptoms of apathy are associated with distinct patterns of brain atrophy in neurodegenerative disorders. J Neurol. 2013;260(10):2481–2490.
62.
RobertPDarcourtGKoulibalyM, et al.Lack of initiative and interest in Alzheimer’s disease: a single photon emission computed tomography study. Eur J Neurol. 2006;13(7):729–735.
63.
MoriTShimadaHShinotohH, et al.Apathy correlates with prefrontal amyloid β deposition in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2014;85(4):449–455.
64.
BenoitMKoulibalyPMMignecoODarcourtJPringueyDJRobertPH. Brain perfusion in Alzheimer’s disease with and without apathy: a SPECT study with statistical parametric mapping analysis. Psychiatry Res. 2002;114(2):103–111.
65.
BenoitMClairetSKoulibalyPDarcourtJRobertP. Brain perfusion correlates of the apathy inventory dimensions of Alzheimer’s disease. Int J Geriatr Psychiatry. 2004;19(9):864–869.
66.
HolthoffVABeuthien-BaumannBKalbeE, et al.Regional cerebral metabolism in early Alzheimer’s disease with clinically significant apathy or depression. Biol psychiatry. 2005;57(4):412–421.
67.
KitamuraSShimadaHNiwaF, et al.Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2018;89(11):1208–1214.
68.
ApostolovaLGAkopyanGGPartialiN, et al.Structural correlates of apathy in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2007;24(2):91–97.
69.
TunnardCWhiteheadDHurtC, et al.Apathy and cortical atrophy in Alzheimer’s disease. Int J Geriatr Psychiatry. 2011;26(7):741–748.
70.
BagbyRMRectorNABacchiochiJRMcBrideC. The stability of the response styles questionnaire rumination scale in a sample of patients with major depression. Cogn Ther Res. 2004;28(4):527–538.
71.
HahnCLimH-KWonWYAhnKJJungWSLeeCU. Apathy and white matter integrity in Alzheimer’s disease: a whole brain analysis with tract-based spatial statistics. PLoS One. 2013;8(1):e53493.
72.
MignecoOBenoitMKoulibalyPM, et al.Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: a study in Alzheimer’s disease and nondemented patients. Neuroimage. 2001;13(5):896–902.
73.
BruenPDMcGeownWJShanksMFVenneriA. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain. 2008;131(9):2455–2463.
74.
BenoitMDygaiIMignecoO, et al.Behavioral and psychological symptoms in Alzheimer’s disease. Dement Geriatr Cogn Disord. 1999;10(6):511–517.
75.
YehYCLiCWKuoYT, et al.Association between altered neurochemical metabolites and apathy in patients with Alzheimer’s disease. Int Psychogeriatr. 2018;30(5):761–768.
76.
KangJYLeeJSKangH, et al.Regional cerebral blood flow abnormalities associated with apathy and depression in Alzheimer disease. Alzheimer Dis Ass Disord. 2012;26(3):217–224.
77.
KazuiHTakahashiRYamamotoY, et al.Neural basis of apathy in patients with amnestic mild cognitive impairment. J Alzheimers Dis. 2017;55(4):1403–1416.
78.
MoonYMoonWJKimHHanSH. Regional atrophy of the insular cortex is associated with neuropsychiatric symptoms in Alzheimer’s disease patients. Eur Neurol. 2014;71(5-6):223–229.
79.
García-AlbercaJMFloridoMCáceresMSánchez-ToroALaraJPGarcía-CasaresN. Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer’s disease. Psychogeriatrics. 2019;19(1):46–54.
80.
TekinSMegaMSMastermanDM, et al.Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol. 2001;49(3):355–361.
81.
MarshallGAGatchelJRDonovanNJ, et al.Regional tau correlates of instrumental activities of daily living and apathy in mild cognitive impairment and Alzheimer’s disease dementia. J Alzheimers Dis. 2019;67(2):757–768.
82.
AlzahraniHAntoniniAVenneriA. Apathy in mild Parkinson’s disease: neuropsychological and neuroimaging evidence. J Parkinsons Dis. 2016;6(4):821–832.
83.
den BrokMGvan DalenJWvan GoolWAMoll van CharanteEPde BieRMRichardE. Apathy in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2015;30(6):759–769.
84.
CohenMLAitaSMariZBrandtJ. The unique and combined effects of apathy and depression on cognition in Parkinson’s disease. J Parkinsons Dis. 2015;5(2):351–359. doi:10.3233/JPD-140484.
85.
ReijndersJSScholtissenBWeberWEAaltenPVerheyFRLeentjensAF. Neuroanatomical correlates of apathy in Parkinson’s disease: a magnetic resonance imaging study using voxel-based morphometry. Mov Disord. 2010;25(14):2318–2325.
86.
RobertGLe JeuneFLozachmeurC, et al.Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology. 2012:79(11):1155–1160. doi:10.1212/WNL.0b013e3182698c75.
87.
HuangCRavdinLDNirenbergMJ, et al.Neuroimaging markers of motor and nonmotor features of Parkinson’s disease: an 18F fluorodeoxyglucose positron emission computed tomography study. Dement Geriatr Cogn Disord. 2013;35(3-4):183–196.
88.
DanRRůžičkaFBezdicekO, et al.Separate neural representations of depression, anxiety and apathy in Parkinson’s disease. Sci Rep. 2017;7(1):12164.
89.
BaggioHCSeguraBGarrido-MillanJL, et al.Resting-state frontostriatal functional connectivity in Parkinson’s disease–related apathy. Mov Disord. 2015;30(5):671–679.
90.
BertouxMVolleEFunkiewiezAde SouzaLCLeclercqDDuboisB. Social Cognition and Emotional Assessment (SEA) is a marker of medial and orbital frontal functions: a voxel-based morphometry study in behavioral variant of frontotemporal degeneration. J Int Neuropsychol Soc. 2012;18(6):972–985.
91.
ZamboniGHueyEKruegerFNichelliPFGrafmanJ. Apathy and disinhibition in frontotemporal dementia Insights into their neural correlates. Neurology. 2008;71(10):736–742.
92.
PetersFPeraniDHerholzK, et al.Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord. 2006;21(5-6):373–379.
93.
PowersJPMassimoLMcMillanCT, et al.White matter disease contributes to apathy and disinhibition in behavioral variant frontotemporal dementia. Cogn Behav Neurol. 2014;27(4):206–214.
94.
RosenHJAllisonSCSchauerGFGorno-TempiniMLWeinerMWMillerBL. Neuroanatomical correlates of behavioural disorders in dementia. Brain. 2005;128(11):2612–2625.
95.
SchroeterMLVogtBFrischS, et al.Dissociating behavioral disorders in early dementia—an FDG-PET study. Psychiatry Res. 2011;194(3):235–244.
96.
KumforFZhenAHodgesJRPiguetOIrishM.Apathy in Alzheimer’s disease and frontotemporal dementia: distinct clinical profiles and neural correlates. Cortex. 2018;103:350–359.
97.
FemianoCTrojsiFCaiazzoG, et al.Apathy is correlated with widespread diffusion tensor imaging (DTI) impairment in amyotrophic lateral sclerosis. Behav Neurol. 2018;2018:2635202.
98.
Martínez-HortaSPerez-PerezJSampedroF, et al.Structural and metabolic brain correlates of apathy in Huntington’s disease. Mov Disord. 2018;33(7):1151–1159.
99.
BonelliRMCummingsJL. Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci. 2007;9(2):141–151.
100.
HollocksMJLawrenceAJBrookesRL, et al.Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes. Brain. 2015;138(12):3803–3815.
101.
MorettiRSignoriR. Neural correlates for apathy: frontal-prefrontal and parietal cortical-subcortical circuits. Front Aging Neurosci. 2016;8:289.
102.
LiuXHairstonJSchrierMFanJ. Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies. Neurosci Biobehav Rev. 2011;35(5):1219–1236.
103.
KringelbachMLRollsET. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Progress Neurobiol. 2004;72(5):341–372.
104.
RollsET. The functions of the orbitofrontal cortex. Brain Cogn. 2004;55(1):11–29.
105.
BecharaADamasioHDamasioAR. Emotion, decision making and the orbitofrontal cortex. Cereb Cortex. 2000;10(3):295–307.
106.
BecharaA. The role of emotion in decision-making: evidence from neurological patients with orbitofrontal damage. Brain Cogn. 2004;55(1):30–40.
107.
SchmidtLd’ArcBFLafargueG, et al.Disconnecting force from money: effects of basal ganglia damage on incentive motivation. Brain. 2008;131(5):1303–1310.
108.
NiendamTALairdARRayKLDeanYMGlahnDCCarterCS. Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions. Cogn Affect Behav Neurosc. 2012;12(2):241–268.
109.
MacDonaldAWCohenJDStengerVACarterCS. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science. 2000;288(5472):1835–1838.
110.
KernsJGCohenJDMacDonaldAW, et al.Decreased conflict-and error-related activity in the anterior cingulate cortex in subjects with schizophrenia. Am J Psychiatry. 2005;162(10):1833–1839.
111.
AlexanderWHBrownJW. The role of the anterior cingulate cortex in prediction error and signaling surprise. Top Cogn Sci. 2019;11(1):119–135.
112.
IannacconeRHauserTUStaempfliPWalitzaSBrandeisDBremS. Conflict monitoring and error processing: new insights from simultaneous EEG–fMRI. Neuroimage. 2015;105:395–407.
113.
PadmalaSSirbuMPessoaL. Potential reward reduces the adverse impact of negative distractor stimuli. Soc Cogn Affect Neurosci. 2017;12(9):1402–1413. doi:10.1093/scan/nsx067
BennYWebbTLChangBPSunYHWilkinsonIDFarrowTFD. The neural basis of monitoring goal progress. Front Hum Neurosci. 2014;8:688.
116.
UddinLQ. Salience processing and insular cortical function and dysfunction. Nat Rev Neurosci. 2015;16(1):55–61.
117.
KnutsonBGreerSM. Anticipatory affect: neural correlates and consequences for choice. Philos Trans R Soc Lon B Biol Sci. 2008;363(1511):3771–3786.
118.
MenonV.Salience network. In TogaAW, ed. Brain Mapping: An Encyclopedic Reference. London, United Kingdom: Academic Press; 2015;2:597–611.
119.
BushGLuuPPosnerMI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci. 2000;4(6):215–222.
120.
PosnerMIDiGirolamoGJ. Conflict, target detection and cognitive control. In ParasuramanR, ed. The Attentive Brain. Cambridge, MA: MIT Press; 1998:401–423.
121.
PausT. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci. 2001;2(6):417–424.
122.
VogtBA. Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci. 2005;6(7):533–544.
123.
WaltonMEBannermanDMAlterescuKRushworthMF. Functional specialization within medial frontal cortex of the anterior cingulate for evaluating effort-related decisions. J Neurosci. 2003;23(16):6475–6479.
124.
CritchleyHDWiensSRotshteinPOhmanADolanRJ. Neural systems supporting interoceptive awareness. Nat Neurosci. 2004;7(2):189–195.
125.
SingerTCritchleyHDPreuschoffK. A common role of insula in feelings, empathy and uncertainty. Trends Cogn Sci. 2009;13(8):334–340.
126.
CraigAD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci. 2002;3(8):655–666.
127.
LammCDecetyJSingerT. Meta-analytic evidence for common and distinct neural networks associated with directly experienced pain and empathy for pain. Neuroimage. 2011;54(3):2492–2502.
128.
BerridgeKCRobinsonTE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?Brain Res Rev. 1998;28(3):309–369.
129.
BerridgeKC. The debate over dopamine’s role in reward: the case for incentive salience. Psychopharmacology (Berl). 2007;191(3):391–431.
130.
MitchellRAHerrmannNLanctôtKL. The role of dopamine in symptoms and treatment of apathy in Alzheimer’s disease. CNS Neuroscience Ther. 2011;17(5):411–427.
131.
DavidRKoulibalyMBenoitM, et al.Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases: a SPECT study with partial volume effect correction. Clin Neurol Neurosurg. 2008;110(1):19–24.
132.
SantangeloGVitaleCPicilloM, et al.Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson’s disease patients. Parkinsonism Relat Disord. 2015;21(5):489–493.
133.
ChongTJHusainM. The role of dopamine in the pathophysiology and treatment of apathy. Prog Brain Res. 2016;229:389–426.
134.
KapurSRemingtonG. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 1996;153(4):466–476.
135.
HoriguchiJInamiYShodaT. Effects of long-term amantadine treatment on clinical symptoms and EEG of a patient in a vegetative state. Clin Neuropharmacol. 1990;13(1):84–88.
136.
KohnoNAbeSToyodaGOguroHBokuraHYamaguchiS. Successful treatment of post-stroke apathy by the dopamine receptor agonist ropinirole. J Clin Neurosci. 2010;17(6):804–806.
137.
PadalaPRBurkeWJBhatiaSC. Modafinil therapy for apathy in an elderly patient. Ann Pharmacother. 2007;41(2):346–349.
138.
Van ReekumRBayleyMGarnerS, et al.N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Inj. 1995;9(1):49–54.
139.
Catsman-BerrevoetsCEHarskampF. Compulsive pre-sleep behavior and apathy due to bilateral thalamic stroke Response to bromocriptine. Neurology. 1988;38(4):647–647.
140.
ParksRCrockettDManjiHAmmannW. Assessment of bromocriptine intervention for the treatment of frontal lobe syndrome: a case study. J Neuropsychiatry Clin Neurosci. 1992;4(1):109–111.
141.
PowellJHAl-AdawiSMorganJGreenwoodRJ. Motivational deficits after brain injury: effects of bromocriptine in 11 patients. J Neurol Neurosurg Psychiatry. 1996;60(4):416–421.
142.
ErkulwaterSPillaiR. Amantadine and the end-stage dementia of Alzheimer’s type. South Med J. 1989;82(5):550–554.
143.
ThoboisSLhomméeEKlingerH, et al.Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain. 2013;136(5):1568–1577.
144.
HerrmannNRothenburgLSBlackSE, et al.Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge. J Clin Psychopharmacol. 2008;28(3):296–301.
145.
PadalaPRBurkeWJShostromVK, et al.Methylphenidate for apathy and functional status in dementia of the Alzheimer type. Am J Geriatr Psychiatry. 2010;18(4):371–374.
146.
WatanabeMDMartinEMDeLeonOAGaviriaMPavelDGTrepashkoDW. Successful methylphenidate treatment of apathy after subcortical infarcts. J Neuropsychiatry Clin Neurosci. 1995;7(4):502–504.
147.
MartoranaAMoriFEspositoZ, et al.Dopamine modulates cholinergic cortical excitability in Alzheimer’s disease patients. Neuropsychopharmacology. 2009;34(10):2323–2328.
KauferDICummingsJLChristineD. Effect of tacrine on behavioral symptoms in Alzheimer’s disease: an open-label study. J Geriatr Psychiatry Neurol. 1996;9(1):1–6.
150.
WaldemarGGauthierSJonesR, et al.Effect of donepezil on emergence of apathy in mild to moderate Alzheimer’s disease. Int J Geriatr Psychiatry. 2011;26(2):150–157.
151.
MorettiRCarusoPDal BenM. Rivastigmine as a symptomatic treatment for apathy in Parkinson’s dementia complex: new aspects for this riddle. Parkinsons Dis. 2017;2017:6219851.
152.
McKeithIDel SerTSpanoP, et al.Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. .2000;356(9247):2031–2036.
153.
ReaRCarotenutoATrainiEFasanaroAMManzoVAmentaF. Apathy treatment in Alzheimer’s disease: interim results of the ASCOMALVA trial. J Alzheimer’s Dis. 2015;48(2):377–383.
154.
BrodatyHBurnsK. Nonpharmacological management of apathy in dementia: a systematic review. Am J Geriatr Psychiatry. 2012;20(7):549–564.
155.
TheleritisCSiarkosKKatirtzoglouEPolitisA. Pharmacological and nonpharmacological treatment for apathy in Alzheimer disease: a systematic review across modalities. J Geriatr Psychiatry Neurol. 2017;30(1):26–49.
156.
ChapmanSBWeinerMFRackleyAHynanLSZientzJ. Effects of cognitive-communication stimulation for Alzheimer’s disease patients treated with donepezil. J Speech Lang Hear Res. 2004;47(5):1149–1463.
157.
HsiehC-JChangCSuS-F, et al.Reminiscence group therapy on depression and apathy in nursing home residents with mild-to-moderate dementia. J Exp Clin Med. 2010;2(2):72–78.
158.
PolitisAMVozzellaSMayerLSOnyikeCUBakerASLyketsosCG. A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care. Int J Geriatr Psychiatry. 2004;19(11):1087–1094.
159.
BakerRHollowayJHoltkamp CC, et al.Effects of multi-sensory stimulation for people with dementia. JAdv Nurs. 2003;43(5):465–477.
160.
Van WeertJCVan DulmenAMSpreeuwenbergPMRibbeMWBensingJM. Behavioral and mood effects of snoezelen integrated into 24-hour dementia care. J Am Geriatr Soc. 2005;53(1):24–33.
161.
StaalJAMatheisRCollierL, et al.The effects of Snoezelen (multi-sensory behavior therapy) and psychiatric care on agitation, apathy, and activities of daily living in dementia patients on a short term geriatric psychiatric inpatient unit. Int J Psychiatry Med. 2007;37(4):357–370.
162.
NiuYXTanJPGuanJQZhangZQWangLN. Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer’s disease: a randomized controlled trial. Clin Rehabil. 2010;24(12):1102–1111.
163.
RaglioABellelliGTraficanteD, et al.Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial. AgingMent Health. 2010;14(8):900–904.
164.
HattoriHHattoriCHokaoCMizushimaKMaseT. Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer’s disease patients. Geriatr Gerontol Int. 2011;11(4):431–437.
165.
TeleniusEWEngedalKBerglandA. Effect of a high-intensity exercise program on physical function and mental health in nursing home residents with dementia: an assessor blinded randomized controlled trial. PLoS One. 2015;10(5):e0126102.
166.
Ferrero-AriasJGoñi-ImízcozMGonzalez-BernalJLara-OrtegaFda Silva-GonzálezADíez-LopezM. The efficacy of nonpharmacological treatment for dementia-related apathy. Alzheimer Dis Assoc Disord. 2011;25(3):213–219.
167.
MaciTPiraFLQuattrocchiGNuovoSDPerciavalleVZappiaM. Physical and cognitive stimulation in Alzheimer disease. the GAIA project: a pilot study. Am J Alzheimer’s Dis Other Demen. 2012;27(2):107–113.
168.
SuemotoCKApolinarioDNakamura-PalaciosEM, et al.Effects of a non-focal plasticity protocol on apathy in moderate Alzheimer’s disease: a randomized, double-blind, sham-controlled trial. Brain Stimul. 2014;7(2):308–313.
169.
AreánPARauePMackinRS, et al.Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction. Am J Psychiatry. 2010;167(11):1391–1398.
170.
AlexopoulosGSRauePJGunningF, et al. “Engage” therapy: behavioral activation and improvement of late-life major depression. Am J Geriatr Psychiatry. 2016;24(4):320–326.
CrowtherASmoskiMJMinkelJ, et al.Resting-state connectivity predictors of response to psychotherapy in major depressive disorder. Neuropsychopharmacology. 2015;40(7):1659.
173.
GawrysiakMJCarvalhoJPRogersBPNicholasCDoughertyJHHopkoDR. Neural changes following behavioral activation for a depressed breast cancer patient: a functional MRI case study. Case Rep Psychiatry. 2012;2012:152916.
